Therapy: Recommendations for the Oncologists
Close collaboration between medical oncologist and other specialists is highly recommended in order to provide the best cures for patients affected by mediastinal tumors. Indeed, the medical oncologist often coordinates the multidisciplinary team involved in the diagnosis and treatment, this latter usually consisting in multimodality approaches. In the last years, immunotherapy and target agents have flanked chemotherapy in the systemic approach of the tumors arising in the mediastinum. Medical oncologist, besides being aware of their activity, should therefore give peculiar attention to the differential toxicities related to the old and new classes of drugs.
KeywordsMultidisciplinary team Surgery Radiotherapy Chemotherapy Immunotherapy Targeted agents
Conflict of Interest Declaration
All authors declare they have no conflict of interest to disclose.
- 1.Henriksen PA. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention. Heart. 2017. [Epub ahead of print].Google Scholar
- 12.Younes A, Santoro A, Shipp M, Zinzani PL, Timmerman JM, Ansell S, et al. Nivolumab for classical Hodgkin’s lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial. Lancet Oncol. 2016;17:1283–94.CrossRefGoogle Scholar